{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:10:41Z","timestamp":1779451841801,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018270","name":"Health Service Executive","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clbc.2025.08.015","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T05:34:19Z","timestamp":1756013659000},"page":"136-145.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Neutrophil-Lymphocyte Ratio as a Predictor of Long-Term Oncological and Survival Outcomes in Patients Treated Surgically for Breast Cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0150-0328","authenticated-orcid":false,"given":"Alisha A.","family":"Jaffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Cullinane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chwanrow","family":"Baban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid Anne","family":"Merrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Tormey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clbc.2025.08.015_bib0001","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/cancers12040958","article-title":"Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review","volume":"12","author":"Corbeau","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0002","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.clbc.2025.08.015_bib0003","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2018.10.042","article-title":"Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer","volume":"488","author":"Han","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"17","key":"10.1016\/j.clbc.2025.08.015_bib0004","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1002\/cam4.4143","article-title":"The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis","volume":"10","author":"Naszai","year":"2021","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.clbc.2025.08.015_bib0005","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.3390\/curroncol29100591","article-title":"Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort","volume":"29","author":"Jalali","year":"2022","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.08.015_bib0006","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.clnu.2019.05.009","article-title":"Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer","volume":"39","author":"Okugawa","year":"2020","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0007","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12885-016-2352-8","article-title":"Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the Tumor Microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.clbc.2025.08.015_bib0009","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0560.2010.01506.x","article-title":"The biologic importance of tumor-infiltrating lymphocytes","volume":"37","author":"Hodi","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil\u2013lymphocyte ratio: Experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.clbc.2025.08.015_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12894-020-00665-8","article-title":"Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis","volume":"20","author":"Shao","year":"2020","journal-title":"BMC Urol"},{"issue":"7","key":"10.1016\/j.clbc.2025.08.015_bib0013","article-title":"Pretreatment Neutrophil-to-Lymphocyte Ratio: A Prognostic Biomarker of Survival in Patients With Epithelial Ovarian Cancer","volume":"13","author":"SO","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12885-018-4230-z","article-title":"Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4048\/jbc.2013.16.1.55","article-title":"Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer Patients","volume":"16","author":"Noh","year":"2013","journal-title":"J Breast Cancer"},{"issue":"8","key":"10.1016\/j.clbc.2025.08.015_bib0016","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.21873\/anticanres.12777","article-title":"Prognostic Significance of Neutrophil\u2013to\u2013lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer","volume":"38","author":"Ferroni","year":"2018","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis","volume":"19","author":"Ethier","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"07","key":"10.1016\/j.clbc.2025.08.015_bib0018","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl Med J"},{"issue":"6","key":"10.1016\/j.clbc.2025.08.015_bib0019","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE Reporting Guidelines for Observational Studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.clbc.2025.08.015_bib0020","first-page":"538","article-title":"The value of follow-up in surgical oncology","volume":"152","author":"van Hillegersberg","year":"2008","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.clbc.2025.08.015_bib0021","series-title":"AJCC Cancer Staging Manual","article-title":"American Joint Committee on Cancer, American Cancer Society","author":"Amin","year":"2017"},{"issue":"3","key":"10.1016\/j.clbc.2025.08.015_bib0022","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4274\/ejbh.galenos.2021.2021-4-3","article-title":"American Joint Committee on Cancer\u2019s Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians","volume":"17","author":"Zhu","year":"2021","journal-title":"Eur J Breast Health"},{"issue":"16","key":"10.1016\/j.clbc.2025.08.015_bib0023","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.08.015_bib0024","series-title":"Pathology and Genetics of Tumours of the Breast and Female Genitale Organs","author":"Tavassoli","year":"2003"},{"issue":"2","key":"10.1016\/j.clbc.2025.08.015_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000350774","article-title":"Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition","volume":"8","author":"Sinn","year":"2013","journal-title":"Breast Care Basel Switz"},{"issue":"19","key":"10.1016\/j.clbc.2025.08.015_bib0027","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2017.76.4258","article-title":"Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor\u2013Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5","volume":"36","author":"Dowsett","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.08.015_bib0028","unstructured":"Gradam Communications Limited. RIP.Ie end of life matters. RIP.ie. https:\/\/rip.ie\/.accessed January 15, 2023."},{"key":"10.1016\/j.clbc.2025.08.015_bib0029","series-title":"Fundamentals of Biostatistics","author":"Rosner","year":"2011"},{"key":"10.1016\/j.clbc.2025.08.015_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","article-title":"Mechanisms of endocrine resistance in breast cancer","volume":"62","author":"Osborne","year":"2011","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.clbc.2025.08.015_bib0031","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ejso.2017.01.089","article-title":"The incidence and consequences of escape from hormonal manipulation in elderly breast cancer patients","volume":"43","author":"Baban","year":"2017","journal-title":"Eur J Surg Oncol EJSO"},{"issue":"3","key":"10.1016\/j.clbc.2025.08.015_bib0032","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijcard.2013.12.019","article-title":"Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III","volume":"171","author":"Shah","year":"2014","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.clbc.2025.08.015_bib0033","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/heartjnl-2020-317510","article-title":"Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors","volume":"107","author":"Matthews","year":"2021","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.clbc.2025.08.015_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.clbc.2025.08.015_bib0035","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3390\/cancers13143472","article-title":"Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clbc.2025.08.015_bib0036","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5114\/ceji.2014.47741","article-title":"The immune response to surgery and infection","volume":"4","author":"D\u0105browska","year":"2014","journal-title":"Cent Eur J Immunol"},{"issue":"8","key":"10.1016\/j.clbc.2025.08.015_bib0037","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2025.08.015_bib0038","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19891115)64:10<2035::AID-CNCR2820641012>3.0.CO;2-L","article-title":"The influence of surgical trauma on experimental metastasis","volume":"64","author":"Murthy","year":"1989","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2025.08.015_bib0039","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1245\/s10434-022-12202-y","article-title":"A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients","volume":"29","author":"Angka","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0040","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1186\/s12885-018-4641-x","article-title":"RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer \u2013 the S.U.R.G.U.V.A.N.T. trial","volume":"18","author":"Redmond","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2025.08.015_bib0041","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"7611","key":"10.1016\/j.clbc.2025.08.015_bib0042","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study","volume":"335","author":"Hippisley-Cox","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.015_bib0043","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity Measures for Use with Administrative Data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"9","key":"10.1016\/j.clbc.2025.08.015_bib0044","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/cncr.31269","article-title":"Adapting the Elixhauser comorbidity index for cancer patients","volume":"124","author":"Mehta","year":"2018","journal-title":"Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:45:22Z","timestamp":1779450322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925002435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1526820925002435"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.08.015","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Neutrophil-Lymphocyte Ratio as a Predictor of Long-Term Oncological and Survival Outcomes in Patients Treated Surgically for Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}